Amerikanische Gesellschaft für Hirudotherapie

Medical Society of Papua New Guinea / National Department of Health — Medicines and Cosmetics Branch

PNG NDoH-MC · Papua New Guinea · oceania

Regulatory jurisdiction profileJurisdictional reference
Unregulatednational regulator

Papua New Guinea's National Department of Health, Medicines and Cosmetics Branch — leech-specific regulatory pathway has not been independently verified by ASH; medicinal leeches fall under the general national medical device framework as appropriate.

Regulatory Profile

Agency type
national regulator
Region
oceania
Country
Papua New Guinea
Leech status
unregulated
Last ASH review
2026-05-26

Relevant Regulation Codes

  • Papua New Guinea Medicines and Cosmetics Act (Chapter 219, Consolidated Laws)
  • Papua New Guinea national medical device regulatory framework

Prescriber Requirements

  • Medical Board of Papua New Guinea–registered physician — order required for any biomedical device application
  • Allied health professional application under physician supervision per institutional protocol

Supply Chain & GMP

National Department of Health registration as applicable; English-language labelling (with Tok Pisin and Hiri Motu at point of dispensing as appropriate). Standard cold-chain conditions, with logistical constraints typical of geographically dispersed Melanesian distribution.

Import/Export Rules

National Department of Health and National Agriculture Quarantine and Inspection Authority clearance for live invertebrates; CITES Appendix II paperwork for Hirudo medicinalis / verbana.

Reimbursement Context

Not covered under public insurance schemes for leech therapy specifically.

ASH Editorial Notes

Leech-specific pathway not independently verified by ASH; falls under general medical device / traditional medicine framework as appropriate. Pacific island regulatory frameworks often rely on regional harmonisation with Australia (TGA) and New Zealand (Medsafe); the exact mechanism for live-organism medical devices has not been independently mapped by ASH.

Related Jurisdictions

Diese Website stellt Bildungsinformationen bereit und ist weder eine medizinische Beratung noch eine Diagnose oder Behandlungsempfehlung. Die medizinische Blutegeltherapie ist mit klinisch relevanten Risiken verbunden und sollte ausschließlich von qualifizierten Klinikerinnen und Klinikern unter institutionell genehmigten Protokollen durchgeführt werden. Die FDA-510(k)-Zulassung für medizinische Blutegel ist auf bestimmte Indikationen beschränkt; experimentelle und Off-Label-Diskussionen werden entsprechend gekennzeichnet. Für patientenspezifische Beratung wenden Sie sich an eine qualifizierte Gesundheitsfachkraft.